Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer
Sponsored by Krankenhaus Barmherzige Schwestern Linz
About this trial
Last updated 3 years ago
Study ID
EKS 39/18
Status
Recruiting
Type
Observational
Placebo
No
Accepting
18 to 99 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 5 years ago
What is this trial about?
The purpose of this study is to determine whether any eventual skin damage caused by
radiation therapy can be detected and monitored at a subclinical level via optical coherence
tomography (OCT). Another key question is whether subclinical OCT detected skin damage
correlates with acute and late clinical toxicity.
What are the participation requirements?
Inclusion Criteria
- Patients with cancer located at: nasopharynx, oropharynx, hypopharynx, larynx, oral cavity and definitive or adjuvant radiation- or radio-chemotherapy
Exclusion Criteria
- reduced mental capacity
- treatment with C225 Cetuximab
- bearded patients
- overt skin disease
- vast tattoos in the neck region
Locations
Location
Status
Recruiting